OpenAI's September 1 announcement lets healthcare organizations connect authorized Epic patient records to ChatGPT, so clinicians can ask what changed since a visit, review labs and medications, and find referrals that were never closed, with summaries pointing back to the chart. On Moonshots with Peter Diamandis, Emad Mostaque called for a sprint to have every health decision double-checked by an AI within a year or two, and Diamandis predicted it would become malpractice to diagnose without AI in the loop — proposals, not current clinical practice.
World Labs released Atlas, a model that generates video along a camera path the user designs and rebuilds scenes from a handful of photographs. Its own garden example shows the seam: one photo leaves the surrounding buildings invented, while more photos pin them down. On Moonshots, the panel worked through what Gaussian splats are and why the approach might matter for robots, games and planning a vacation.
A Moonshots panel watched video of Tesla's two-seat Cybercabs moving through Austin and spent most of the segment on a price: the roughly $30,000 the panel says Elon Musk wants to charge for the car, and what happens if ordinary people buy a handful each and put them to work. Their forecasts of twenty-cent miles and car-free city centers sit alongside Tesla's own more modest description of a limited Austin service — and alongside London, where Uber's first autonomous rides still carry a licensed driver.
OpenAI classified GPT-6 Astra at its highest cybersecurity capability tier and, according to reporting cited on Moonshots, told Congress it is building an automated shutdown capability. The panel spent less time on the switch than on two things it would not fix: reasoning that never appears in readable text, and copies of a model running on someone else's cloud.
On Moonshots, the panel revisits Elon Musk's January prediction that models were "off by two orders of magnitude" in intelligence per gigabyte, after Tim Sweeney tweeted that it had come true and Musk replied that specialist AIs add another 100x. Dave calls 100x a lower bound and asks what anyone would actually do with 10,000 brilliant agents; Emad Mostaque describes running specialized agent teams, while Alex argues Musk's "specialist models" are really sparsification inside generalist models.
On Moonshots, Peter Diamandis described a new Unitree humanoid as hitting 12.66 metres per second after three months of development. Salim Ismail said the lesson is to stop copying humans; Alex argued general-purpose robots will swallow the specialists; Emad Mostaque predicted extreme machines will be kept off the street, and Alex proposed consumer, industrial and military classes.
On Moonshots, Peter Diamandis reported back from meetings with SK hynix and Solidigm leadership with a claim that memory, not compute, now limits AI. The panel argued that a changed workload and a supplier industry scarred by past busts are pushing prices up faster than factories can respond — and that the fix may be new chip designs, including etching model weights into silicon, rather than simply paying more.
GenBio AI's AIDO Cell simulates a human cell that holds its state across a sequence of interventions, and the Moonshots panel watched a demo and began sketching the end of medicine. The article explains what the simulator does today — prioritizing experiments in two prototype cell lines, with laboratory validation of novel predictions still underway — and separates that from the panel's proposals: an AlphaGo-style search from diseased to healthy cells, open public biology data, and frontier labs paying for all of it.
Merck and Moderna said on August 19 that intismeran autogene, an mRNA therapy manufactured separately for every patient, met its main endpoints alongside Keytruda in a 1,137-patient melanoma trial. On the Moonshots podcast, the panel walked through the sequencing-and-machine-learning workflow behind it and argued about whether drug regulation can cope with a treatment that is different for each person.
On Moonshots with Peter Diamandis, an operator described a bad coding idea spreading through a swarm of 5,000 identical AI agents until he intercepts and rewinds them — otherwise, he says, roughly $50,000 of tokens goes into a harebrained plan. The panel set that experience beside a new paper on "mind viruses" that spread between agents through editable memory, and argued about whether "virus" is the right word.
On Moonshots, the panel works through a report that Anthropic is designing its IPO to keep its founders in control. Untangling economic ownership, voting power and the Long-Term Benefit Trust's board-selection rights leads to a sharper disagreement: whether anyone outside a founding group can realistically hold the steering wheel of a frontier AI lab.
OpenAI said on August 18 that it had halted part of its frontier reinforcement-learning work until alignment, security and monitoring standards caught up with the capabilities ahead. On Moonshots with Peter Diamandis, Emad Mostaque called the safety constraint real, Alex called the announcement marketing, and Salim Ismail reported back from a visit to OpenAI's offices. OpenAI later disclosed that the largest paused run restarted on August 28.